Hence, preservation of BAT, and insulin sensitivity in BAT and residual WAT, may at least partly explain why Ad-B2(−/−) mice do not develop the overt metabolic disease seen in PPARγ-FKO and IR-FKO mice. Here, ITGAD is linked to metabolic disease.